Skip to main content
. Author manuscript; available in PMC: 2024 Feb 19.
Published in final edited form as: Sci Transl Med. 2023 Mar 8;15(686):eabl4414. doi: 10.1126/scitranslmed.abl4414

Fig. 4. Pharmacological depletion of NK cells reduces tumor growth, progression, and metastasis in murine TNBC.

Fig. 4.

(A) Schematic shows experimental approach of NK cell depletion for preventative (large tumor) setting. A total of 140,000 primary tumor cells from C3-HET mice were injected into the mammary fat pads (MFPs) of REAR mice. (B) Percentage of NK cells (CD45+DX5+) of CD45+ cells in C3-HET primary tumors upon anti-NK1.1 treatment compared with control tumors. (C) Representative images of tumors (left) and tumor growth curve (right) upon NK cell depletion in the preventative setting (n = 8 tumors per group). (D) Representative tumor images (left) and tumor growth curve (right) showing tumor progression for BRCA1cKO tumor–bearing mice (n = 6 tumors for IgG and n = 8 tumors for NK1.1). A total of 125,000 primary tumor cells per MFP from BRCA1cKO mice were injected into C57BL/6 mice. Arrowheads in (C) and (D) indicate the start point for drug dose. (E) Percentage of NK cells (CD45+CD3DX5+) of CD45+CD3 cells in primary BRCA1cKO tumors upon NK cell depletion compared with control tumors. (F) Cleaved caspase-3 staining (left) and quantification (right) show apoptotic cells in primary tumors upon NK cell depletion (n = 3 individual tumors per group and n = 24 random fields per group for quantification). (G) Representative IHC images (right) and quantification (left) show CD34+ blood vessels in NK cell–depleted primary tumors (n = 4 individual tumors for control and n = 3 for NK cell depletion, with analysis of n = 12 random fields from IgG tumors and n = 13 random fields from NK1.1-depleted tumors for quantification). (H) Flow cytometry analysis showing percentage of CD4+CD8 T cells of CD3+ T cells in primary C3-HET tumors upon NK cell depletion compared with control tumors. (I) IF staining (left) and quantification (right) of PD-L1 in primary tumors upon NK cell depletion (n = 4 individual tumors, with analysis of n = 10 random fields per group for quantification). The scatterplots show the number per group of samples from flow analysis. Two-tailed Student’s t test was used to compute P values for all scatterplots. Data are presented as the mean ± SEM. Statistical significance was determined by two-way ANOVA with Sidak’s multiple comparisons test in (C), (D), and (F). **P = 0.0011, ***P = 0.0003, and ****P < 0.0001. Scale bars, 100 μm.